pentobarbital will lower the extent or outcome of buprenorphine, extended-acting injection by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Sufferers who transfer to buprenorphine prolonged-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers really should be monitored to